Shares Outstanding Shares Outstanding n/a Close	13.83M
Shares Change (YoY) Shares Change (YoY) n/a Close	1.71%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0.06%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	42.07%
Shares Floating Shares Floating n/a Close	6.12M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	8
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.02%

Short Selling Information

The latest short interest is 95.32K, so 0.69% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	95.32K
Short % of Shares Out Short % of Shares Out n/a Close	0.69%
Short % of Float Short % of Float n/a Close	1.66%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	5.53

Valuation Ratios

The PE ratio is -9.03 and the forward PE ratio is 33.86. Champions Oncology's PEG ratio is -0.23.

PE Ratio PE Ratio n/a Close	-9.03
Forward PE Forward PE n/a Close	33.86
PS Ratio PS Ratio n/a Close	1.31
Forward PS Forward PS n/a Close	1.3
PB Ratio PB Ratio n/a Close	-34.53
P/FCF Ratio P/FCF Ratio n/a Close	-9.42
PEG Ratio PEG Ratio n/a Close	-0.23

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Champions Oncology.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of -3.9.

Current Ratio Current Ratio n/a Close	0.63
Quick Ratio Quick Ratio n/a Close	0.63
Debt / Equity Debt / Equity n/a Close	-3.9
Debt / EBITDA Debt / EBITDA n/a Close	-1.47
Debt / FCF Debt / FCF n/a Close	-1.07
Interest Coverage Interest Coverage n/a Close	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$238,833.33
Profits Per Employee Profits Per Employee n/a Close	$-34,647.62
Employee Count Employee Count n/a Close	210
Asset Turnover Asset Turnover n/a Close	1.92
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	-32K
Effective Tax Rate Effective Tax Rate n/a Close	0.44%

Stock Price Statistics

The stock price has increased by 44.36% in the last 52 weeks. The beta is 0.37, so Champions Oncology's price volatility has been higher than the market average.

Beta Beta n/a Close	0.37
52-Week Price Change 52-Week Price Change n/a Close	44.36%
50-Day Moving Average 50-Day Moving Average n/a Close	6.84
200-Day Moving Average 200-Day Moving Average n/a Close	7.13
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	50.84
Average Volume (20 Days) Average Volume (20 Days) n/a Close	36,487

Income Statement

In the last 12 months, Champions Oncology had revenue of 50.16M and earned -7.28M in profits. Earnings per share was -0.54.

Revenue Revenue n/a Close	50.16M
Gross Profit Gross Profit n/a Close	20.75M
Operating Income Operating Income n/a Close	-7.36M
Net Income Net Income n/a Close	-7.28M
EBITDA EBITDA n/a Close	-5.05M
EBIT EBIT n/a Close	-6.92M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-0.54

Full Income Statement

Balance Sheet

The company has 2.62M in cash and 7.43M in debt, giving a net cash position of -4.81M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	2.62M
Total Debt Total Debt n/a Close	7.43M
Net Cash Net Cash n/a Close	-4.81M
Retained Earnings Retained Earnings n/a Close	-84.59M
Total Assets Total Assets n/a Close	30.63M
Working Capital Working Capital n/a Close	-173K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.14M and capital expenditures -836K, giving a free cash flow of -6.97M.

Operating Cash Flow Operating Cash Flow n/a Close	-6.14M
Capital Expenditures Capital Expenditures n/a Close	-836K
Free Cash Flow Free Cash Flow n/a Close	-6.97M
FCF Per Share FCF Per Share n/a Close	-0.51

Full Cash Flow Statement

Margins

Gross margin is 41.38%, with operating and profit margins of -14.67% and -14.51%.

Gross Margin Gross Margin n/a Close	41.38%
Operating Margin Operating Margin n/a Close	-14.67%
Pretax Margin Pretax Margin n/a Close	-14.57%
Profit Margin Profit Margin n/a Close	-14.51%
EBITDA Margin EBITDA Margin n/a Close	-10.08%
EBIT Margin EBIT Margin n/a Close	-14.67%
FCF Margin FCF Margin n/a Close	-13.9%

Dividends & Yields

CSBR does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for CSBR is $12, which is 64.6% higher than the current price. The consensus rating is "Strong Buy".

Price Target Price Target n/a Close	$12
Price Target Difference Price Target Difference n/a Close	64.6%
Analyst Consensus Analyst Consensus n/a Close	Strong Buy
Analyst Count Analyst Count n/a Close	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Aug 12, 2015. It was a backward split with a ratio of 1:12.

Last Split Date Last Split Date n/a Close	Aug 12, 2015
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:12

Scores

Altman Z-Score Altman Z-Score n/a Close	4.6
Piotroski F-Score Piotroski F-Score n/a Close	5